Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_assertion type Assertion NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_head.
- NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_assertion description "[We investigated the clinical impact of the expression of PTEN, p-Akt and PI3K in HER2-positive metastatic breast cancer (MBC) patients treated with trastuzumab-based therapies.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_provenance.
- NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_assertion evidence source_evidence_literature NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_provenance.
- NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_assertion SIO_000772 20389136 NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_provenance.
- NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_assertion wasDerivedFrom befree-20150227 NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_provenance.
- NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_assertion wasGeneratedBy ECO_0000203 NP625283.RAcqLef0TY8t95EfTRpTSRMl87R8fajKbRA1lXQGPtQFo130_provenance.